查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2078292

外科止血鉗、內部組織密封膠和黏連預防材料市場：按產品類型、應用、最終用戶和地區分類。

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Product Type, By Application, By End User, and By Region
出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026年，外科止血鉗、組織組織密封膠和防沾黏材料的市場規模估計為66.079億美元，預計到2033年將達到113.247億美元。預計從2026年到2033年，其複合年成長率將達到8.0%。

分析範圍 分析詳情
基準年 2025 市場規模（2026 年） 66.079億美元
效能數據 2020-2024 預測期 2026-2033
預測期（2026-2033 年）複合年成長率 8.00% 預計金額（2033 年） 113.247億美元

手術止血鉗是用來控制出血的手術器械。在手術初期，通常會將止血鉗置於初始切口處，以封閉待結紮的血管。內組織密封膠是一種可吸收材料，透過封閉組織來控制內出血。因此，它們可以防止體液從手術傷口滲漏。這些是用於黏合組織並輔助修復的外科黏合劑和黏合劑。另一方面，防沾黏材料是用來防止組織和器官在癒合過程中形成內部沾黏的醫用植入。藥物和材料，例如動物源性膜、金箔、礦物油、橡膠片和特氟龍，均可用於降低粘連形成的風險。這三種外科材料用於控制術中和術後出血。

市場動態

意外事故和燒燙傷發生率的上升、心血管疾病盛行率的增加以及新產品的法規核准，正在推動全球外科止血鉗、組織組織密封膠和防沾黏材料市場的成長要素。例如，2021年2月23日，美國醫療設備製造商EndoClot Plus Inc.的創新產品EndoClot多醣止血系統（EndoClot PHS）獲得美國食品藥物管理局（FDA）的批准。該產品能夠快速可靠地止住消化道出血。 EndoClot PHS是一種一次性醫療設備，內含澱粉基粉末止血劑，可透過軟式內視鏡直接施用於出血部位。這種可吸收改質聚合物（AMP）粉末能夠快速凝血，促進正常的生理凝血過程。當 AMP 粉末與胃腸道中的血液和體液接觸時，會形成凝膠狀基質，起到機械屏障的作用，進一步抑制出血。

本報告的主要特點

  • 本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
  • 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
  • 本頁面根據各種參數（公司概況、產品系列、主要趨勢、財務表現、策略等）對全球外科止血鉗、組織組織密封膠和黏連預防材料市場的主要公司進行了介紹。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
  • 《全球外科止血鉗、組織密封膠和防粘連材料市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過分析全球外科止血鉗、組織組織密封膠和防沾黏材料市場中使用的各種策略矩陣來促進決策。

目錄

第1章：分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 近期產品發布
  • 流行病學
  • 企業合併、商業合作
  • 監管趨勢
  • 主要進展
  • PEST分析

第4章：全球外科止血鉗、組織密封膠和防沾黏材料市場：依產品類型分類（2021-2033 年）

  • 止血鉗
  • 內組織密封膠
  • 防沾黏材料

第5章：全球外科止血鉗、組織密封膠和防沾黏材料市場：按應用領域分類（2021-2033 年）

  • 外科應用
  • 創傷病例

第6章：全球外科止血鉗、組織密封膠和防沾黏材料市場：依最終使用者分類（2021-2033 年）

  • 醫院
  • 門診手術中心
  • 專科診所

第7章 全球外科止血鉗、組織密封膠和防沾黏材料市場：按類型分類（2021-2033 年）

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • Ethicon（Johnson & Johnson）
  • Baxter International Inc
  • Integra LifeSciences Holdings Corporation
  • Pfizer Inc
  • Tissuemed Ltd.
  • Sanofi
  • Braun Melsungen AG
  • R. Bard, Inc
  • CryoLife, Inc.
  • Cohera Medical, Inc
  • CSL Behring

第9章

  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI3721

Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market is estimated to be valued at USD 6,607.9 Mn in 2026 and is expected to reach USD 11,324.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 6,607.9 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 8.00% 2033 Value Projection: USD 11,324.7 Mn

A surgical hemostat is a surgical tool used to control bleeding. It is common in the initial phases of surgery for the initial incision to be lined with hemostats that close blood vessels awaiting ligation. Internal tissue sealants are absorbable materials used to control internal bleeding by sealing the tissue. Thus, they can prevent leaks of fluid from the surgical incision. These are surgical glues and adhesives used for attaching tissue to one other to help in repair. While, adhesion barriers are the medical implants used to prevent the formation of internal adherence between tissues, and organs when they are healing. Drugs and materials such as animal membranes, gold foil, mineral oil, sheets of rubber, and Teflon are used to reduce the risk of adhesion formation. These three surgical materials are used to control bleeding during and after surgical procedures.

Market Dynamics

Increasing incidences of accidents and burns, increasing prevalence of cardiovascular diseases, and approvals of new products by regulatory authorities are attributed to the growth of the global surgical hemostats, internal tissue sealants, and adhesion barriers market. For instance, on February 23, 2021, EndoClot Plus Inc., a U.S.-based medical device company, received U.S. Food and Drug Administration approval (FDA) for its product EndoClot Polysaccharide Hemostatic System (EndoClot PHS), an innovative product that helps to stop gastrointestinal bleeding rapidly and reliably. EndoClot PHS is a single-use device including a starch-based powder hemostat that is applied directly to the bleeding site through a flexible endoscope. The Absorbable Modified Polymer (AMP) powder can quickly concentrate the blood to accelerate the normal physiological clotting process. A gelled matrix forms when the AMP powder contacts blood or fluid in the GI tract to provide a mechanical barrier to further control bleeding.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global surgical hemostats, internal tissue sealants, and adhesion barriers market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Ethicon (Johnson & Johnson), Baxter International Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi, Braun Melsungen AG, C.R. Bard, Inc., CryoLife, Inc., Cohera Medical, Inc., and CSL Behring
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global surgical hemostats, internal tissue sealants, and adhesion barriers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global surgical hemostats, internal tissue sealants, and adhesion barriers market.

Detailed Segmentation:

  • Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Product Type (Revenue, USD Mn, 2021 - 2033)
  • Hemostats
    • Thrombin Based
    • Combination Hemostats
    • Oxidized Regenerated Cellulose Based
    • Gelatin Based
    • Collagen Based
  • Internal Tissue Sealants
    • Fibrin Based
    • Collagen Based
    • Protein Based
    • Synthetic Polymer Based
  • Adhesion Barriers
    • Film Based
    • Gel Based
    • Solution Based
  • Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By Application (Revenue, USD Mn, 2021 - 2033)
  • Surgical Applications
    • Cardiovascular Surgeries
    • Neurological Surgeries
    • Orthopedic Surgeries
    • Urological & Gynecological Surgeries
    • General Surgeries
    • Reconstructive and Plastic Surgeries
    • Others
  • Trauma Cases
  • Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market, By End User (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
  • Ethicon (Johnson & Johnson)
  • Baxter International Inc.
  • Integra LifeSciences Holdings Corporation
  • Pfizer Inc.
  • Tissuemed Ltd.
  • Sanofi
  • Braun Melsungen AG
  • R. Bard, Inc.
  • CryoLife, Inc.
  • Cohera Medical, Inc.
  • CSL Behring

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Application
    • Market Snapshot, By End user
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market, By Product Type, 2021-2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hemostat
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Segment Trends
      • Thrombin Based
      • Combination Hemostats
      • Oxidized Regenerated Cellulose Based
      • Gelatin Based
      • Collagen Based
  • Internal Tissue Sealants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Segment Trends
      • Fibrin Based
      • Collagen Based
      • Protein Based
      • Synthetic Polymer Based
  • Adhesion Barrier
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Segment Trends
      • Film Based
      • Gel Based
      • Solution Based

5. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market, By Application, 2021-2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Surgical Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
    • Segment trends
      • Cardiovascular Surgeries
      • Neurological Surgeries
      • Orthopedic Surgeries
      • Urological & Gynecological Surgeries
      • General Surgeries
      • Reconstructive and Plastic Surgeries
      • Others
  • Trauma Cases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market, By End user, 2021-2033, (US$ Million)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

7. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market, By Region, 2021-2033, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021- 2033, (US$ Million)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Ethicon (Johnson & Johnson)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Baxter International Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Integra LifeSciences Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Tissuemed Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • R. Bard, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CryoLife, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cohera Medical, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CSL Behring
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us